1
Published 2015
Canadian Agency for Drugs and Technologies in Health
... metabolite bind to [mu]-opioid receptors in the central nervous system resulting in inhibition of ascending...

2
Published 2015
CADTH Rapid Response Service
... gamma aminobutyric acid (GABA) but does not bind to the GABA receptors. Its mechanism of action...

3
Published 2015
CADTH Rapid Response Service
... gamma aminobutyric acid (GABA) but does not bind to the GABA receptors. Its mechanism of action...

6
Published 2020
Canadian Agency for Drugs and Technologies in Health
... at least four migraine days monthly.It is a monoclonal antibody that binds to and inhibits calcitonin gene...

7
Published 2020
Canadian Agency for Drugs and Technologies in Health
...-inflammatory by binding to the glucocorticoid receptor. Budesonide is formulated as a 1 mg orodispersible...

8
Published 2016
Canadian Agency for Drugs and Technologies in Health
... mechanisms of action; specifically, daptomycin works by binding or inserting into the outer membrane, while...

9
Published 2016
Canadian Agency for Drugs and Technologies in Health
... mechanisms of action; specifically, daptomycin works by binding or inserting into the outer membrane, while...

10
Published 2018
CADTH
... that binds selectively to the interleukin 23 (IL-23) protein with high specificity and affinity. Levels of IL...

11
Published 2017
Canadian Agency for Drugs and Technologies in Health
... the beneficial and harmful effects of GPB as a nitrogen-binding agent adjunctive to dietary protein restriction...

12
Published 2020
Canadian Agency for Drugs and Technologies in Health
...Vedolizumab is a humanized immunoglobulin G1 monoclonal antibody that binds exclusively...

13
Published 2020
Canadian Agency for Drugs and Technologies in Health
...Vedolizumab is a humanized immunoglobulin G1 monoclonal antibody that binds exclusively...

14
Published 2020
Canadian Agency for Drugs and Technologies in Health
... antibody that binds to the N-terminal domain of FGF23. The Health Canada-recommended starting dose...

15
Published 2020
Canadian Agency for Drugs and Technologies in Health
... antibody that binds to the N-terminal domain of FGF23. The Health Canada-recommended starting dose...

16
Published 2016
Canadian Agency for Drugs and Technologies in Health
..., spinal instability, and compression of the spinal cord. Denosumab is a human monoclonal antibody binding...

17
Published 2017
CADTH
... antibody that binds specifically to both soluble and membrane-bound interleukin-6 receptors inhibiting...

18
by Janoudi, Ghayath, McCormack, Suzanne
Published 2020
Canadian Agency for Drugs and Technologies in Health
.... Nusinersen is an antisense oligonucleotide that binds to the SMN2 pre-messenger ribonucleic acid, this leads...

19
Published 2016
Canadian Agency for Drugs and Technologies in Health
... or in combination with methotrexate. Ustekinumab is a fully human IgG1 kappa monoclonal antibody that binds...

20
Published 2016
Canadian Agency for Drugs and Technologies in Health
... or in combination with methotrexate. Ustekinumab is a fully human IgG1 kappa monoclonal antibody that binds...